Using PCORnet® to Compare Blood Pressure Control Strategies: COVID 19 and Antihypertensive Medication Use Supplement
Study PI(s): Mark Pelcher, University of California San Francisco; Madalaine Faulkner, University of California San Francisco; Rhonda Cooper-DeHoff, University of Florida
Project Summary: This individual-level randomized control trial (RCT), conceived and led in partnership with patients, will recruit patients with an elevated systolic blood pressure (SBP) at their last ambulatory care visit and provide free home blood pressure (BP) monitoring devices with randomly allocated device type (Bluetooth-enabled versus standard). Researchers will measure patient-prioritized outcomes including demonstrated attainment of patient's personal BP goal, self-reported belief that doctor is using accurate measurements to adjust medications, device ease and frequency of use, and quality of shared decision-making. Outcomes will be compared overall and within subgroups including lower income patients, African-American and Hispanic patients.
Study Design: Multi-CRN Data-only Observational
PaTH Partners:
- University of Pittsburgh (Kathleen McTigue, Site PI)
- Penn State University (Cynthia Chuang, Site PI)
- Johns Hopkins University (Harold Lehmann, Site PI)
Sponsor: PCORI®
The Using PCORnet® to Compare Blood Pressure Control Strategies: COVID 19 and Antihypertensive Medication Use Supplement study is a PCORnet® Study conducted using PCORnet®, the National Patient Centered Clinical Research Network, an initiative funded by the Patient-Centered Outcomes Research Institute (PCORI). More information about PCORnet® can be found here.
The study was funded by PCORI through PCORI Award (PaCR-2017C2-8153).
The statements presented on this website are solely the responsibility of the author(s) and do not necessarily represent the views of other organizations participating in, collaborating with, or funding PCORnet or of PCORI.
